Serum proprotein convertase subtilisin/Kexin type 9 and vascular disease in type 2 diabetic patients

被引:3
作者
Armentaro, Giuseppe [1 ]
Carbone, Federico [2 ,3 ]
Cassano, Velia [1 ,5 ]
Liberale, Luca [2 ,3 ]
Minetti, Silvia [2 ]
Bertolotto, Maria Bianca [2 ]
Mannino, Gaia [1 ]
Fiorentino, Teresa V. [1 ]
Perticone, Maria [1 ]
Succurro, Elena [1 ]
Sesti, Giorgio [4 ]
Montecucco, Fabrizio [2 ]
Andreozzi, Francesco [1 ]
Sciacqua, Angela [1 ]
机构
[1] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy
[2] Univ Genoa, Dept Internal Med, Clin Internal Med 1, Genoa, Italy
[3] IRCCS Osped Policlin San Martino Genoa, Genoa, Italy
[4] Sapienza Univ Rome, Dept Clin & Mol Med, Rome, Italy
[5] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, I-88100 Catanzaro, Italy
关键词
arterial stiffness; atherosclerosis; hypertension; PCSK9; PWV; type; 2; diabetes; PLASMA PCSK9 LEVELS; BLOOD-CELL COUNT; ARTERIAL STIFFNESS; AORTIC STIFFNESS; REDUCING LIPIDS; RISK; ASSOCIATION; EFFICACY; SAFETY; STROKE;
D O I
10.1111/eci.13900
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundProprotein Convertase Subtilisin/Kexin type 9 (PCSK9) levels have been suggested as novel atherosclerotic biomarker. PCSK9 plays important roles in the pathogenesis of atherosclerosis by regulating the degradation of low-density lipoprotein receptor as well as different inflammatory pathways. Considering the important prognostic role of arterial stiffness in cardiovascular disease (CVD), the aim of the study is to investigate the correlation between PCSK9 levels and arterial stiffness in a cohort of diabetic patients, without previous CV events. MethodsThis cross-sectional analysis enrolled 401 Caucasian patients with type II diabetes mellitus (T2DM). PCSK9 levels were measured by ELISA test, arterial stiffness was estimated by measuring carotid-femoral pulse wave velocity (PWV). ResultsPatients were divided in three tertiles according to increasing value of PCSK9. From the I to the III tertiles, there was a significant increase in high sensitivity C-reactive protein (hs-CRP), fibrinogen and white blood cells (WBC) and a reduction in estimated glomerular filtration rate (e-GFR). Patients with higher levels of PCSK9 presented increased systolic, diastolic blood pressure, pulse pressure and PWV. PWV was significantly and directly correlated with PCSK9, fibrinogen, age, BMI and PP, and indirectly correlated with diet, lifestyle and e-GFR. Serum PCSK9 was the major predictor of PWV, justifying a 16.9% of its variation. ConclusionOur study demonstrates a close association between circulating PCSK9 levels and PWV in T2DM subjects without previous CV events even after adjusting for well-known CV risk factor and pharmacological medications. Serum PCSK9 could be a useful biomarker for CV risk stratification in diabetic subjects.
引用
收藏
页数:9
相关论文
共 32 条
  • [1] Metabolic and cardiovascular risk factors in subjects with impaired fasting glucose: the 100 versus 110 mg/dL threshold
    Andreozzi, Francesco
    Succurro, Elena
    Mancuso, Maria Rosaria
    Perticone, Maria
    Sciacqua, Angela
    Perticone, Francesco
    Sesti, Giorgio
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2007, 23 (07) : 547 - 550
  • [2] [Anonymous], 2016, DIABETES CARE, V39, pS1, DOI [10.2337/dc19-Sint01, 10.2337/dc16-S001, 10.2337/dc20-Sint, 10.2337/dc19-SINT01, 10.2337/dc20-SINT]
  • [3] Arterial stiffness and microvascular disease in type 2 diabetes
    Antonopoulos, Alexios S.
    Siasos, Gerasimos
    Oikonomou, Evangelos
    Gouliopoulos, Nikolaos
    Konsola, Theodosia
    Tsigkou, Vasiliki
    Moschos, Marilita
    Tentolouris, Nikolaos
    Kassi, Eva
    Paschou, Stavroula A.
    Thanopoulou, Anastasia
    Vavuranakis, Manolis
    Stone, Peter
    Antoniades, Charalambos
    Tousoulis, Dimitris
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2021, 51 (02)
  • [4] Circulating PCSK9 and cardiovascular events in FH patients with standard lipid-lowering therapy
    Cao, Ye-Xuan
    Jin, Jing-Lu
    Sun, Di
    Liu, Hui-Hui
    Guo, Yuan-Lin
    Wu, Na-Qiong
    Xu, Rui-Xia
    Zhu, Cheng-Gang
    Dong, Qian
    Sun, Jing
    Li, Jian-Jun
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17 (01)
  • [5] Uric Acid and Vascular Damage in Essential Hypertension: Role of Insulin Resistance
    Cassano, Velia
    Crescibene, Daniele
    Hribal, Marta Letizia
    Pelaia, Corrado
    Armentaro, Giuseppe
    Magurno, Marcello
    Toscani, Alfredo
    Miceli, Sofia
    Andreozzi, Francesco
    Maio, Raffaele
    Perticone, Maria
    Sesti, Giorgio
    Perticone, Francesco
    Sciacqua, Angela
    [J]. NUTRIENTS, 2020, 12 (09) : 1 - 11
  • [6] Beyond cholesterol metabolism: The pleiotropic effects of proprotein convertase subtilisin/kexin type 9 (PCSK9). Genetics, mutations, expression, and perspective for long-term inhibition
    Cesaro, Arturo
    Bianconi, Vanessa
    Gragnano, Felice
    Moscarella, Elisabetta
    Fimiani, Fabio
    Monda, Emanuele
    Scudiero, Olga
    Limongelli, Giuseppe
    Pirro, Matteo
    Calabro, Paolo
    [J]. BIOFACTORS, 2020, 46 (03) : 367 - 380
  • [7] Sequence variations in PCSK9, low LDL, and protection against coronary heart disease
    Cohen, JC
    Boerwinkle, E
    Mosley, TH
    Hobbs, HH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (12) : 1264 - 1272
  • [8] Association of serum proprotein convertase subtilisin/kexin type 9 with early atherosclerosis in newly diagnosed type 2 diabetes mellitus
    Guo, Wen
    Gong, Yingyun
    Li, Jie
    Qin, Pei
    Lu, Jing
    Li, Xiaona
    Zhu, Wenfang
    Xu, Nianzhen
    Zhou, Hongwen
    Zhang, Qun
    [J]. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2019, 29 (08) : 815 - 821
  • [9] Plasma PCSK9 levels are unrelated to arterial stiffness in a community-based, 4.8-year prospective study
    Han, J.
    Wang, X.
    Ye, P.
    Cao, R.
    Yang, X.
    Xiao, W.
    Zhang, Y.
    Bai, Y.
    Wu, H.
    [J]. JOURNAL OF HUMAN HYPERTENSION, 2017, 31 (11) : 720 - 724
  • [10] Genetic and Metabolic Determinants of Plasma PCSK9 Levels
    Lakoski, Susan G.
    Lagace, Thomas A.
    Cohen, Jonathan C.
    Horton, Jay D.
    Hobbs, Helen H.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (07) : 2537 - 2543